This blog is an effort to sift through the noise. Please note that a number of resources are used to create these theses and due to an overriding desire to think rather than edit I will not be citing every little source.
Search This Blog
Wednesday, April 30, 2014
Activist Investors and the Search for Alpha
At the Milken Conference they hosted a panel on activist investing. It was a star studded panel featuring: Clifton Robinson, Jeff Ubben, Barry Rosenstein, and Chris Teets. Worth listening to. Enjoy:
Thursday, April 24, 2014
Marcato Capital Presentation at Active-Passive Investing Summit
Mick McGuire of Marcato Capital recently gave a presentation at the Active-Passive Investor Summit. He gave reasons why he is long Sotheby's (where he recently announced he is siding with Dan Loeb and Pershing Square) and Dillard's (DDS).
ENjoy:
Marcato-Sothebys-Dillards.pdf
Wednesday, April 23, 2014
Pershing Square Presentation on Allergan
Following the big news of Bill Ackman's fund Pershing Square taking a stake in Allergan (AGN) Pershing has produced their customary lengthy slide presentation.
Enjoy:
Tuesday, April 22, 2014
Greenlight Capital Q1 2014 Letter
Below please find Greenlight Capital's Q1 2014 letter to investors. In the letter David Einhorn talks about his concerns on a pending tech bubble. We also find out that Greenlight ended Q1 down 1.5%. They established positions in SUNE, CONN, ATC, and Resona. Great stuff as always. Enjoy:
Barry Rosenstein the head of JANA on CNBC
Barry Rosenstein the head of JANA was on CNBC today talking about activist investing and his recent stake in Walgreen's (WAG). He thinks WAG has a lot of value levers to pull.
Jeff Ubben on CNBC (part 2)
Here is part 2 of the Jeff Ubben interview on CNBC. In this interview he shares his thoughts on Microsoft (MSFT).
Enjoy:
Jeff Ubben on CNBC (part 1)
Jeff Ubben of ValueAct Capital was on CNBC recently sharing his opinion on Microsoft (MSFT) and Valeant Pharmaceuticals (VRX). Here is the first interview in which he shares his thoughts on VRX and the recent news that Bill Ackman's Pershing Square is partnering with the company to help it take over Allergan.
Enjoy:
Tuesday, April 15, 2014
Dan Loeb's latest Presentation on Sotheby's
The battle is heating up a bit now with some back and forth between Dan Loeb and Sotheby's. Enjoy:
Thursday, April 3, 2014
Jim Chanos on CNBC talking about the Slow Death of the PC
Jim Chanos was on CNBC today talking about the slow death of the PC industry. He is long the innovators like Apple and Samsung but is short HPQ, IBM, and the disk drive maker. He thinks they will lose out to the cloud movement - Google and Amazon even make their own servers. Over half of HPQ's cash flow is from factoring receivables which they only disclose in the footnotes and they changed management incentive to FCF. He is not short Microsoft since he thinks they are figuring out the cloud.
Jim Chanos - CAT Short is No Brainer
Jim Chanos on CNBC today talking about why his short in Caterpillar (CAT) is a no brainer as they are a derivative of the Chinese economy and will collapse with it.
Jim Chanos on CNBC
Jim Chanos was on CNBC today discussing how tough it is shorting and how Sotheby's (BID) is one of the best bubble indicators.
Tuesday, April 1, 2014
Michael Mauboussin AIC Keynote
Michael Mauboussin gave the keynote address at the recent 17th annual Credit Suisse Asian Investment Conference. His talk was about his recent book and how to untangle skill and luck in the business context. Its good stuff. Enjoy:
Subscribe to:
Posts (Atom)